The Karnataka Government on Tuesday said it has granted Rs 10.70 crore to 26 startups in the BioTech sector.
The 26 winners of the Idea2PoC (proof of concept), an initiative organised by the Karnataka Startup Cell, Department of IT, received cheques up to Rs. 50 lakhs (each) in the first tranche from the minister on Tuesday.
The grant has been given under the Idea2PoC (proof of concept) programme – an initiative organised by the Karnataka Startup Cell, Department of IT and is implemented by the Bangalore Bioinnovation Centre (BBC), a Section 8 company set up by KBITS to nurture and promote startups in the field of biotechnology.
Priyank Kharge, Minister of IT, BT & Tourism, Government of Karnataka said,
“Idea2POC offers entrepreneurs a holistic support system to explore, develop and launch their best ideas. The scheme is designed to identify, mentor and fund enterprising biotech startups in Karnataka who can create a deep social impact on the lives of people of Karnataka.”
The State unveiled its startup policy in November 2015 with the an aim of nurturing 20,000 technology-based startups and 6,000 product-based firms.
Some of the winner startups are :
Bendflex Research & Development Pvt Ltd: This medical devices company develops mechanical biomarkers for in-vitro fertilization.
Omix Research and Diagnostics Laboratories Pvt Ltd: Omix is looking to develop a tool for the detection and surveillance of antimicrobial resistance among urinary tract infections.
Aprus Biomedical Innovations Pvt Ltd: The company is looking to develop an advanced wound care device for treating recalcitrant diabetic ulcers.
Nesa Medtech Pvt Ltd: This company develops an affordable and minimally invasive therapeutic procedure to treat symptomatic uterine fibroids in reproductive women.
Pentavalent Bio Sciences Private Limited: The company’s product is a DNA cassette-based decision-making tool for treating tuberculosis patients.
Lumisoft Technologies Pvt Ltd: The company is developing a potable digital slit lamp that can diagnose 70% of conditions causing blindness.
DF3D CREATIONS Pvt Ltd: The company is developing a cloud-based pre-surgical planning platform that leverages 3D printing technology to create patient-specific models and surgical guides.
Hanugen Therapeutics Private Limited: The company supplies anti-sense oligonucleotides, which is used for treating genetic disorders and infections.
Terra Blue Exploration Technologies Pvt Ltd: The company is developing a solution to predict and manage epilepsy.
Next Big Innovation Labs Pvt Ltd :The company is looking to develop India’s first 3D bio-printer and its medical applications.
“Our focus is to create a strong start-up ecosystem with ideation at the bottom of the pyramid. These are not relationships based on a single conference meeting, but ones that are forged through meaningful experiences we have gone through together,”
said Gaurav Gupta, Karnataka Principal Secretary, Department of IT, BT.